ArticleInternational journal of nanomedicine2020

A Mansonone Derivative Coupled with Monoclonal Antibody 4D5-Modified Chitosan Inhibit AKR1C3 to Treat Castration-Resistant Prostate Cancer.

Meng Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.